Viridian Therapeutics
VRDN
VRDN
46 hedge funds and large institutions have $25M invested in Viridian Therapeutics in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
33% less capital invested
Capital invested by funds: $37.4M → $25M (-$12.3M)
Holders
46
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.08M | |
| 2 | +$977K | |
| 3 | +$347K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$239K |
| 5 |
Jane Street
New York
|
+$159K |
Top Sellers
| 1 | -$2.04M | |
| 2 | -$1.4M | |
| 3 | -$747K | |
| 4 |
FAM
Formidable Asset Management
Cincinnati,
Ohio
|
-$430K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$175K |